Analyst Price Targets — BSX
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| April 22, 2026 9:18 pm | David Roman | Goldman Sachs | $84.00 | $64.87 | TheFly | Boston Scientific price target lowered to $84 from $87 at Goldman Sachs |
| April 22, 2026 7:04 pm | Matthew Taylor | Jefferies | $100.00 | $64.87 | StreetInsider | Boston Scientific (BSX) PT Lowered to $100 at Jefferies |
| April 21, 2026 11:13 am | Rick Wise | Stifel Nicolaus | $85.00 | $60.99 | TheFly | Boston Scientific price target lowered to $85 from $90 at Stifel |
| April 15, 2026 12:24 pm | — | Truist Financial | $90.00 | $64.92 | TheFly | Boston Scientific price target lowered to $90 from $92 at Truist |
| April 13, 2026 2:36 pm | — | Mizuho Securities | $90.00 | $62.06 | TheFly | Boston Scientific price target lowered to $90 from $115 at Mizuho |
| March 26, 2026 10:06 pm | — | Goldman Sachs | $93.00 | $70.17 | TheFly | Boston Scientific price target lowered to $93 from $98 at Goldman Sachs |
| February 17, 2026 12:00 pm | William Plovanic | Canaccord Genuity | $109.00 | $74.73 | TheFly | Boston Scientific price target lowered to $109 from $112 at Canaccord |
| February 6, 2026 1:56 pm | Lee Hambright | Bernstein | $112.00 | $77.46 | TheFly | Boston Scientific price target lowered to $112 from $130 at Bernstein |
| February 5, 2026 3:02 pm | — | Truist Financial | $95.00 | $77.02 | TheFly | Boston Scientific price target lowered to $95 from $120 at Truist |
| February 5, 2026 2:20 pm | — | RBC Capital | $115.00 | $77.17 | TheFly | Boston Scientific price target lowered to $115 from $130 at RBC Capital |
Latest News for BSX
NEW YORK, April 22, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the “Class Period”), of the important May 4, 2026 lead plaintiff deadline.
New York, New York--(Newsfile Corp. - April 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Boston Scientific Corporation (NYSE: BSX) between July 23, 2025 and February 3, 2026, inclusive (the "Class Period"), of the important May 4, 2026 lead plaintiff deadline. SO WHAT: If you purchased Boston Scientific common stock during the Class Period you may be…
Expand NYSE: BSX Boston Scientific Today's Change (8.99%) $5.35 Current Price $64.87 Key Data Points Market Cap $88B Day's Range $61.78 - $65.32 52wk Range $59.38 - $109.50 Volume 40M Avg Vol 17M Gross Margin 65.04% Boston Scientific (BSX +8.99%), a medical device developer, closed Wednesday at $64.87, up 8.99%. The stock is jumping after a Q1 earnings beat paired with lowered 2026 guidance.
Boston Scientific Corporation (BSX) Q1 2026 Earnings Call Transcript
Boston Scientific meets Q1 EPS estimates, posts 11.6% revenue growth and beats sales estimates, but cuts 2026 outlook; shares still climb in premarket trading.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.